Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR
Authors
Keywords
Alcoholic liver injury, Farnesoid X receptor, Yangonin, Lipid homeostasis, Cellular senescence
Journal
PHYTOMEDICINE
Volume 90, Issue -, Pages 153629
Publisher
Elsevier BV
Online
2021-06-18
DOI
10.1016/j.phymed.2021.153629
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Geniposide reduces cholesterol accumulation and increases its excretion by regulating the FXR-mediated liver-gut crosstalk of bile acids
- (2020) Jinxin Liu et al. PHARMACOLOGICAL RESEARCH
- Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease
- (2020) Tiangang Li et al. Hepatobiliary Surgery and Nutrition
- FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury
- (2019) Bo Kong et al. DIGESTIVE AND LIVER DISEASE
- Yangonin protects against estrogen–induced cholestasis in a farnesoid X receptor-dependent manner
- (2019) Renchao Dong et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Natural products, extracts and formulations comprehensive therapy for the improvement of motor function in alcoholic liver disease
- (2019) Shuang Hu et al. PHARMACOLOGICAL RESEARCH
- Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo
- (2018) Lingli Zheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Oroxylin A inhibits ethanol-induced hepatocyte senescence via YAP pathway
- (2018) Huanhuan Jin et al. CELL PROLIFERATION
- Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice
- (2018) Phillipp Hartmann et al. HEPATOLOGY
- The Pharmacology, Pharmacokinetics, Efficacy, and Adverse Events Associated With Kava
- (2018) C. Michael White JOURNAL OF CLINICAL PHARMACOLOGY
- Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro
- (2018) Xiaoguang Gao et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR
- (2018) Kavita Jadhav et al. Molecular Metabolism
- Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver
- (2018) Tao Zeng et al. Redox Biology
- Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor
- (2018) Renchao Dong et al. PHYTOMEDICINE
- n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review
- (2018) Meng Wang et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Pathophysiology and Management of Alcoholic Liver Disease: Update 2016
- (2017) Felix Stickel et al. Gut and Liver
- Protective effect of polysaccharide from maca ( Lepidium meyenii ) on Hep-G2 cells and alcoholic liver oxidative injury in mice
- (2017) Lijun Zhang et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Bile acids and colon cancer: Is FXR the solution of the conundrum?
- (2017) Raffaella Maria Gadaleta et al. MOLECULAR ASPECTS OF MEDICINE
- TZAP: A telomere-associated protein involved in telomere length control
- (2017) Julia Su Zhou Li et al. SCIENCE
- Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation
- (2017) Yimeng Zhang et al. TOXICOLOGY
- Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
- (2017) Sukhpreet Singh et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation
- (2016) Delia Blaya et al. GUT
- Betulin alleviated ethanol-induced alcoholic liver injury via SIRT1/AMPK signaling pathway
- (2016) Ting Bai et al. PHARMACOLOGICAL RESEARCH
- Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes
- (2015) Chunfeng Lu et al. IUBMB LIFE
- Alcoholic liver disease: mechanisms of injury and targeted treatment
- (2015) Alexandre Louvet et al. Nature Reviews Gastroenterology & Hepatology
- Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis
- (2015) Qiang Meng et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Alcohol withdrawal alleviates adipose tissue inflammation in patients with alcoholic liver disease
- (2014) Cosmin S. Voican et al. LIVER INTERNATIONAL
- Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease
- (2013) Weibin Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Kavalactone content and chemotype of kava beverages prepared from roots and rhizomes of Isa and Mahakea varieties and extraction efficiency of kavalactones using different solvents
- (2013) Jun Wang et al. JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE
- A Comprehensive Model for the Recognition of Human Telomeres by TRF1
- (2013) Michael Garton et al. JOURNAL OF MOLECULAR BIOLOGY
- Kavalactones and the endocannabinoid system: The plant-derived yangonin is a novel CB1 receptor ligand
- (2012) Alessia Ligresti et al. PHARMACOLOGICAL RESEARCH
- Redox Signaling and the Innate Immune System in Alcoholic Liver Disease
- (2010) Jessica I. Cohen et al. ANTIOXIDANTS & REDOX SIGNALING
- The Protein Network Surrounding the Human Telomere Repeat Binding Factors TRF1, TRF2, and POT1
- (2010) Richard J. Giannone et al. PLoS One
- Kavalactones Protect Neural Cells against Amyloid Peptide-Induced Neurotoxicity via Extracellular Signal-Regulated Kinase 1/2-Dependent Nuclear Factor Erythroid 2-Related Factor 2 Activation
- (2008) C. J. Wruck et al. MOLECULAR PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now